MAOB and Parkinson disease: Most drugs used for PD act to maintain dopamine levels in the brain, by either increasing them (levodopa and dopamine agonists) or preventing their decrease (monoamine oxidase-B, MAO-B, inhibitors such as rasagiline and selegiline).